From Name

From Email

To Name

To Email

Message

FDA approves new drug to treat hospital-acquired pneumonia

from Medical Economics

FDA approves new drug to treat hospital-acquired pneumonia Medical Economics The FDA has approved a new drug called Recarbrio to treat hospital acquired pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP). Recarbrio has previously been used to treat patients with urinary tract complications and is a last resort for intraabdominal infections. READ MORE

more